DS

Digvijay Sinha

Active Director Director DIN 06458588
DIN 06458588 First appointment Feb 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2013
Shareholding value •••• Premium profile

About Digvijay Sinha

Data last updated:

Digvijay Sinha is a Director at Ergon Pharmaceutical Private Limited (since 2013). The company operates in Pharma. Ergon Pharmaceutical Private Limited reported revenue of ₹5.7 Lakh (FY 2019).

DIN 06458588
Primary Designation Director
Industry Pharma
First Appointment 19 Feb 2013
Oldest Company Age 13 yrs
Largest company Ergon Pharmaceutical Private Limited · ₹5.7 Lakh (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ergon Pharmaceutical Private Limited U52310BR2013PTC019884
Director19 Feb 20132013₹5.7 Lakh (FY 2019)Active

Board colleagues of Digvijay Sinha

Directorship timeline

Open interactive timeline →
Ergon Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Digvijay Sinha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Digvijay Sinha

Digvijay Sinha currently holds 1 directorship: Ergon Pharmaceutical Private Limited (Director, since 19 Feb 2013, revenue ₹5.7 Lakh (FY 2019)).

Digvijay Sinha was first appointed on 19 Feb 2013 as Director at Ergon Pharmaceutical Private Limited.

The current boards of Digvijay Sinha's companies include Arun Kumar (Ergon Pharmaceutical Private Limited), Prakash Singh (Ergon Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available